Thorac Cardiovasc Surg 2016; 64(08): 688-692
DOI: 10.1055/s-0036-1587699
Original Cardiovascular
Georg Thieme Verlag KG Stuttgart · New York

The Role of Blood Transfusion in the Development of Atrial Fibrillation after Coronary Artery Bypass Grafting

Athanasia Vlahou
1   Departement of CardiothoracicSurgery, General Hospital George Papanikolaou, Thessaloniki, Greece
,
Konstantinos Diplaris
1   Departement of CardiothoracicSurgery, General Hospital George Papanikolaou, Thessaloniki, Greece
,
Fotini Ampatzidou
1   Departement of CardiothoracicSurgery, General Hospital George Papanikolaou, Thessaloniki, Greece
,
Lampos Karagounnis
2   Departement of Cardiology, Interbalkan Medical Center, Thessaloniki, Greece
,
George Drossos
1   Departement of CardiothoracicSurgery, General Hospital George Papanikolaou, Thessaloniki, Greece
› Author Affiliations
Further Information

Publication History

30 December 2016

04 July 2016

Publication Date:
30 August 2016 (online)

Abstract

Objectives Atrial fibrillation (AF) is the most common complication after coronary artery bypass grafting (CABG). It is associated with prolonged hospital stay and increased cost. The aim of this study is to investigate the relationship between transfusion of blood derivatives and occurrence of postoperative paroxysmal AF.

Materials and Methods From June 2012 to February 2014, 446 patients undergoing CABG with cardiopulmonary bypass (CPB) were prospectively evaluated for occurrence of postoperative AF. Patients and procedural variables were recorded and were associated with the development of new-onset AF with logistic regression analysis.

Results AF developed in 111 patients (24.9%). Preoperative factors associated with the development of new-onset AF included age (p < 0.05), higher EuroSCORE II (p < 0.05), carotid disease (p = 0.01), peripheral vascular disease (p = 0.02), chronic obstructive pulmonary disease (p = 0.03), renal failure (p = 0.05), and cardiac failure (p = 0.01). Intraoperative and postoperative parameters included duration of CPB (p < 0.05), number of grafts (p = 0.009), intubation time (p = 0.001), occurrence of postoperative stroke (p = 0.01), transient ischemic attack (p = 0.02), need for prolonged ventilation (p = 0.002), development of respiratory tract infection (p = 0.02), need for noninvasive ventilation (p = 0.001), reintubation (p = 0.02), development of postoperative acute kidney injury (p = 0.002), and postoperative neurocognitive dysfunction (p = 0.002). The number of red blood cell (RBC) units transfused during surgery (p = 0.7) and the total number of RBC units transfused (p = 0.2) as well as units of fresh frozen plasma (p = 0. 7) and platelets units transfused in total (p = 0.3) were not found to increase the risk of postoperative AF.

Conclusion Intraoperative and postoperative blood products transfusion in patients operated for CABG is not associated with increased risk of developing postoperative AF.

 
  • References

  • 1 Hakala T, Pitkanen O, Hartikainen J. Cardioplegic arrest does not increase the risk of atrial fibrillation after coronary artery bypass surgery. Eur J Cardiothorac Surg 2004; 25 (3) 415-418
  • 2 Patel D, Gillinov MA, Natale A. Atrial fibrillation after cardiac surgery: where are we now?. Indian Pacing Electrophysiol J 2008; 8 (4) 281-291
  • 3 Almassi GH, Schowalter T, Nicolosi AC , et al. Atrial fibrillation after cardiac surgery: a major morbid event?. Ann Surg 1997; 226 (4) 501-511 , discussion 511–513
  • 4 Van Wagoner DR. Electrophysiological remodeling in human atrial fibrillation. Pacing Clin Electrophysiol 2003; 26 (7 Pt 2): 1572-1575
  • 5 Allessie MA, Boyden PA, Camm AJ , et al. Pathophysiology and prevention of atrial fibrillation. Circulation 2001; 103 (5) 769-777
  • 6 Helgadottir S, Sigurdsson MI, Ingvarsdottir IL, Arnar DO, Gudbjartsson T. Atrial fibrillation following cardiac surgery: risk analysis and long-term survival. J Cardiothorac Surg 2012; 7: 87
  • 7 Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007; 115 (2) 135-143
  • 8 Efremidis M, Bramos D. The emerging role of inflammation and fibrosis in atrial fibrillation and the potential role of counter interventions. Athens Cardiology Update 2008, Hospital Chronicles 2008; 2 (Suppl): 144-150
  • 9 Papoulidis P, Ananiadou O, Chalvatzoulis E , et al. The role of ascorbic acid in the prevention of atrial fibrillation after elective on-pump myocardial revascularization surgery: a single-center experience—a pilot study. Interact Cardiovasc Thorac Surg 2011; 12 (2) 121-124
  • 10 Drossos G, Koutsogiannidis CP, Ananiadou O , et al. Pericardial fat is strongly associated with atrial fibrillation after coronary artery bypass graft surgery. Eur J Cardiothorac Surg 2014; 46 (6) 1014-1020 , discussion 1020
  • 11 Huang CX, Liu Y, Xia WF, Tang YH, Huang H. Oxidative stress: a possible pathogenesis of atrial fibrillation. Med Hypotheses 2009; 72 (4) 466-467
  • 12 Koch CG, Li L, Van Wagoner DR, Duncan AI, Gillinov AM, Blackstone EH. Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg 2006; 82 (5) 1747-1756
  • 13 Choi YS, Shim JK, Hong SW, Kim DH, Kim JC, Kwak YL. Risk factors of atrial fibrillation following off-pump coronary artery bypass graft surgery: predictive value of C-reactive protein and transfusion requirement. Eur J Cardiothorac Surg 2009; 36 (5) 838-843
  • 14 Karkouti K. Transfusion and risk of acute kidney injury in cardiac surgery. Br J Anaesth 2012; 109 (1) (Suppl. 01) i29-i38